Orders from 1390 SEK Free delivery from 2895 SEK Ready for pickup dead drop: collect in 5 min Free parcel delivery from 2895 SEK

Substances · Cathinone derivatives

4-CMC

C10H12ClNO CAS 1225843-86-6 Analytical reference material — not for human consumption
4-CMC, educational illustration of the molecular structure
Educational illustration of the molecular structure. This is not a photograph of the product.
Preferred name
4-CMC
IUPAC name
1-(4-chlorophenyl)-2-(methylamino)propan-1-one
Parent CAS number (reference)
1225843-86-6
Molecular formula
C10H12ClNO
Molecular weight
197.66 g/mol
InChIKey
UEJBEYOXRNGPEI-UHFFFAOYSA-N
PubChem
CID 82100418
Source
PubChem
Verified synonyms & catalog abbreviations
Clephedrone 4-Chloromethcathinone 4CMC 4 CMC

Verified Neurochemical & Toxicological Intelligence

4-CMC (Clephedrone / 4-Chloromethcathinone)

Entactogen / Stimulant (Serotonin-Rich SNDRA) Substituted cathinone (para-chlorinated methcathinone)
Verified PubChem & CAS Identity C10H12ClNO · CAS 1225843-86-6 · CID 82100418
Calibrated Physical Form Pure Crystalline / Analytical Powder (≥98%)
≥98% Analytical Purity Verified 197.66 g/mol
Peer-Reviewed & Agency Citations 4 · verified sources

Receptor Telemetry & Mechanism of Action

DAT Dopamine Transporter 42.2 nM
NET Norepinephrine Transporter 44 nM
SERT Serotonin Transporter 144 nM

Functions primarily as a substrate-type serotonin-norepinephrine-dopamine releasing agent (SNDRA) with low SERT/DAT selectivity (~3.4) closely resembling mephedrone (4-MMC). In rat brain synaptosomes (Walther et al., 2018), 4-CMC releases dopamine (DAT EC50 = 42.2 nM), norepinephrine (NET EC50 = 44 ± 9 nM), and serotonin (SERT EC50 = 144 nM), alongside moderate uptake inhibition (IC50: 208 nM DAT, 670 nM SERT). Para-chlorination shifts subjective feel toward warm, dreamy serotonergic mood elevation, though preclinical studies indicate elevated oxidative stress and cytotoxicity relative to 4-MMC.

Biotransformation & Active Metabolites

Metabolized via N-demethylation to 4-chlorocathinone and carbonyl reduction to dihydro-4-CMC. Human observational oral studies (75–150 mg) reveal a significantly delayed oral-fluid concentration peak and delayed onset of subjective and cardiovascular effects compared to methylone.

Temporal Pharmacokinetics

Warm, soothing, serotonergic-leaning entactogen-stimulant producing emotional openness, tactile enhancement, relaxed body mood elevation, and moderate sociability with less sharp motor drive than 3-CMC.

  1. Onset 20–60 minutes oral (delayed absorption relative to methylone; 10–30 minutes mucosal)
  2. Peak Window 1–2 hours
  3. Total Window 2–4 hours oral (vital-sign and cortisol shifts persist across 5 hours; 1–2 hours mucosal)
  4. Residual / Half-Life 3–12 hours of insomnia, serotonergic fatigue, and mood dip; exact human elimination half-life is unverified.

Critical delayed-onset hazard: human observational studies confirm that oral 4-CMC reaches peak fluid levels and peak subjective effects noticeably later than methylone. repeated exposure during the first 45–60 minutes because 'nothing is happening yet' frequently causes abrupt, overwhelming serotonergic-sympathomimetic toxicity, hyperthermia, and oxidative stress.

Quantitative Response Spectrum (Published Literature)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
20–30 mg
Cognitive & Sensory

Gentle mood softening, mild anxiety reduction, and subtle sensory brightening.

Somatic & Autonomic

Slight warmth in the chest and extremities with minimal pulse shift.

Light
30–50 mg
Cognitive & Sensory

Relaxed sociability, mild tactile pleasure, emotional comfort, and light music enhancement.

Somatic & Autonomic

Modest elevation in heart rate, slight pupil dilation, and mild dry mouth.

Common Reference
50–100 mg (human observational cohorts tested 75–150 mg)
Cognitive & Sensory

Distinct 4-MMC-like serotonergic warmth, empathy, lowered inhibitions, heightened libido, and dreamy contentment.

Somatic & Autonomic

Dilated pupils with slowed pupillary light reflex, elevated systolic blood pressure and heart rate, sweating, jaw clenching, and mild balance softening.

Strong
100–150 mg
Cognitive & Sensory

Heavy, sedating-mood-elevating immersion, slurred or slowed speech, short-term memory lapses, and disorientation.

Somatic & Autonomic

Strong bruxism, hyperthermia, nausea on come-up, impaired balance (positive Romberg sign), and marked peripheral vasoconstriction.

Heavy / Toxic Zone
150–180+ mg
Cognitive & Sensory

Acute agitation, fear, hallucinations, aggression, serotonergic delirium, or psychotic episodes.

Somatic & Autonomic

Severe hyperthermia, chest pain, arrhythmias, hypertension, seizures, oxidative neurotoxicity, and multi-organ stress.

Interaction Matrix & Critical Contraindications

Critical Hazard — Never Combine

MAOIs (moclobemide, phenelzine, selegiline, harmala alkaloids)

Potent serotonin and catecholamine release from 4-CMC combined with MAO blockade precipitates rapid, fatal serotonin syndrome and hypertensive crisis.

Serotonergic agents and Tramadol (MDMA, 4-MMC, 3-CMC, 5-MAPB, 6-APB, DXM, 5-HTP)

High SERT release potency (EC50 = 144 nM) makes additive serotonergic combinations prone to life-threatening hyperthermia, clonus, and seizures.

Strong stimulants and vasoconstrictors (Cocaine, alpha-PVP, alpha-PHP, 25x-NBOMe)

Synergistic hypertension, vasospasm, and cardiac strain elevate risk of stroke or cardiac arrest.

Elevated Hazard — Avoid

Alcohol

Compounds dehydration, motor ataxia, oxidative burden, and delayed depressant rebound once 4-CMC wears off.

Psychedelics with high body load (2C-E, ETH-LAD)

Heightens thermoregulatory strain, vasoconstriction, and acute anxiety during 4-CMC's rapid offset.

Caution / Receptor Attenuation

SSRIs and SNRIs

Blocks SERT-mediated serotonin efflux, muting 4-CMC's signature empathogenic warmth while retaining cardiovascular side effects and serotonin-toxicity risk at high amounts.

Cannabis

Can intensify dizziness, tachycardia, and short-term confusion during peak or comedown.

Structural Isomer & Sibling Comparison

4-CMC is the most serotonergic of the three chloromethcathinone isomers (SERT EC50 144 nM vs. 211 nM for 3-CMC and 2,815 nM for 2-CMC), giving it a softer, warmer, more 'rolly' feel than brisk, dopaminergic 3-CMC and plain-stimulant 2-CMC. Compared to 4-MMC (mephedrone), 4-CMC has lower standard oral reference brackets on TripSit (50–100 mg vs. 100–200 mg) while feeling shorter, slower to peak orally, and carrying stronger preclinical cytotoxicity and oxidative-stress signals.

Physicochemical Stability & Storage

Physical Form: White, off-white, or pale yellowish crystalline solid or translucent crystal chunks as the hydrochloride salt (mp ~198 °C). · Soluble in PBS (pH 7.2, ~5 mg/mL), ethanol (~5 mg/mL), DMF (~5 mg/mL), and DMSO (~10 mg/mL).

Unstable in warm aqueous or biological matrices due to beta-keto reduction; store dry in an airtight, light-protected container at cool or sub-zero temperatures.

Cross-Tolerance & Dependence Profile

Rapid tolerance to serotonergic mood elevation within a single session, with cross-tolerance across all cathinones, MDMA, and amphetamines. Because para-chlorinated cathinones induce marked cytotoxicity and oxidative stress in vitro, frequent or back-to-back sessions carry heightened neurochemical risks; multi-week recovery intervals are strongly advised.

Codes on this card

Short meanings for the abbreviations printed with this substance.

Open the full glossary →
DAT Dopamine transporter

DAT is the protein that collects dopamine back from the gap between nerve cells. A card that names DAT is quoting a laboratory result about that protein.

NET Norepinephrine transporter

NET is the protein that collects norepinephrine, also called noradrenaline, back into the nerve cell. Cards cite it when a lab report shows activity at that transporter.

SERT Serotonin transporter

SERT is the protein that collects serotonin back into the nerve cell. A higher number than at DAT means the serotonin transporter needed more concentration to reach the halfway point.

SNDRA / NDRI Releaser or reuptake blocker

An SNDRA is carried in and the cell releases serotonin, norepinephrine, and dopamine. An NDRI mainly slows the vacuum at norepinephrine and dopamine. The class line says which one the papers describe.

EC₅₀ / IC₅₀ Halfway concentration

EC50 is the concentration where a lab saw half of the maximum measured effect. IC50 is the concentration where it saw half of the maximum block. Smaller means that halfway point came at a lower concentration.

isomer Isomers

Isomers share the same atoms in the same counts, but the atoms are arranged differently. They can share a molecular formula and still be different chemicals, with different CAS numbers and different lab results.

5-HT ↑↑ Serotonergic Overload (Serotonin Toxicity)

A potentially fatal medical emergency caused by excessive synaptic serotonin (for example when mixing two serotonin releasers, MAOIs, or tramadol), marked by hyperthermia and neuromuscular rigidity.

HR / Naczynia Vasoconstriction & Cardiovascular Load

Narrowing of peripheral blood vessels, elevated blood pressure, and rapid heart rate driven by strong noradrenergic and dopaminergic stimulation.

Comprehensive Analytical & Toxicological Monograph

4-CMC (clephedrone; 1-(4-chlorophenyl)-2-(methylamino)propan-1-one; freebase CAS 1225843-86-6, hydrochloride CAS 2319878-22-1, PubChem CID 82100418) is the para-chlorinated positional isomer of methcathinone, supplied as pure analytical crystals or crystalline powder (C10H12ClNO, 197.66 g/mol). In rat brain synaptosomal assays, 4-CMC acts as a balanced serotonin-norepinephrine-dopamine releasing agent (DAT EC50 = 42.2 nM, NET EC50 = 44 nM, SERT EC50 = 144 nM; SERT/DAT ratio ~3.4), closely mirroring the transporter profile of 4-MMC while inducing higher oxidative stress and cytotoxicity in preclinical models. Human observational studies following 75–150 mg oral intake demonstrate a characteristic delayed absorption and delayed peak compared to methylone, alongside measurable increases in systolic blood pressure, heart rate, and salivary cortisol across a 5-hour observation window. Documented oral brackets place threshold effects at 20–30 mg, light relaxation and sociability at 30–50 mg, common empathogenic-stimulant activity at 50–100 mg, strong intensity with slowed speech and motor ataxia at 100–150 mg, and heavy overdose risk above 150–180 mg. Oral onset spans 20–60 minutes with a 2–4 hour primary duration and 3–12 hours of residual insomnia; waiting out the full 60-minute come-up before considering any redose is essential to avoid stacked serotonergic toxicity. Compared to its regioisomers, 4-CMC is noticeably warmer, dreamier, and less edgy than meta-isomer 3-CMC, and vastly more empathogenic than catecholamine-selective ortho-isomer 2-CMC, though shorter-acting and less mood-elevating than 4-MMC. Never mix 4-CMC with MAOIs, MDMA, 4-MMC, 5-MAPB, tramadol, DXM, cocaine, pyrovalerones, or 25x-NBOMe compounds due to fatal serotonin syndrome, hyperthermia, and cardiovascular collapse.

Chemical Architecture & Structural Profile

4-CMC (1-(4-chlorophenyl)-2-(methylamino)propan-1-one) is a reference compound belonging to the Cathinone derivatives class, characterized by the molecular formula C10H12ClNO and a molar mass of 197.66 g/mol. The parent molecule is indexed under CAS registry number 1225843-86-6 and in the NCBI PubChem database as CID 82100418 (Standard InChIKey: UEJBEYOXRNGPEI-UHFFFAOYSA-N). This molecule shares its empirical formula (C10H12ClNO) with positional or structural isomers; unambiguous analytical identification requires matching the full IUPAC structure, CAS number (1225843-86-6), and spectroscopic profile.

Citations

Reference Toxicology & Safety Profile

In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), 4-CMC is indexed within the Cathinone derivatives structural group. As a substituted beta-ketone (cathinone derivative), this compound requires strict analytical verification and has documented contraindications with MAOIs, serotonergic agents, and other stimulants. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.

Citations

Analytical Use & Laboratory Notice

This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.

Citations